23andMe 23andMe

CRISPR and other gene technology is exciting, but shouldn't be seen as a panacea for treating illness linked to genetic mutations, says science columnist and author Carl Zimmer. It's still early days for the clinical applications of research. Westend61/Getty Images hide caption

toggle caption
Westend61/Getty Images

A Science Writer Explores The 'Perversions And Potential' Of Genetic Tests

  • Download
  • <iframe src="https://www.npr.org/player/embed/618870881/618969757" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript